depression linked to an autoimmune thyroid condition may have poor prognosis

Main Category: Depression
Article Date: 15 Mar 2004 - 0:00 PDT


Whether depression is linked to having an under-active thyroid gland has been debated for many years. Research published in BMC Psychiatry this week suggests that some patients with depression may be suffering from a subtle autoimmune thyroid condition, which could hinder their recovery.

The study also suggests that physicians could use indicators of thyroid function to predict patients' responsiveness to antidepressants. As inpatients with depression often undergo routine thyroid tests, the data that physicians would need to create such a prediction are likely to be available to them already.

Researchers from Greece studied 30 patients suffering from major depression, and 60 healthy people as controls. Each patient was examined by two psychiatric experts, who assessed their condition during a structured interview. The researchers then tested the thyroid function of all the volunteers.

Although the levels of the thyroid function indicators FT3, FT4 and TSH, fell inside the normal range for all the people studied, suffering from depression appeared to increase the level of thyroid binding inhibitory immunoglobulins in the blood of some patients. High levels of these immunoglobulins can subtly inhibit the function of the thyroid gland.

The authors write: 'Although thyroid dysfunction is not common in depression there is evidence suggesting the presence of an underlying autoimmune process affecting the thyroid gland in depressive patients…The finding that depression often co-exists with autoimmune subclinical thyroiditis suggests that depression may cause alterations in the immune system, or that in fact it is an autoimmune disorder itself.'

Two years after the initial examination, the patients were re-assessed, to find out how well they had responded to treatment for their condition. The patients' responsiveness was associated with the levels of thyroid hormone and thyroid binding inhibitory immunoglobulin in their blood.

By creating an algorithm based on the indicators of thyroid function, the researchers were able to predict patients' response to antidepressants with an almost 90% success rate. Higher immunoglobulin levels were associated with a reduced responsiveness to treatment, indicating that specific therapeutic intervention could be needed to help these patients to recover.

Indicators of thyroid function could also be used as a diagnostic tool. When plugged into a different algorithm, they predicted which patients were suffering from depression in 80% of cases.

As the size of this study is relatively small, further research will be necessary to confirm these findings, and to understand whether the thyroid condition is the cause of the depression or vice versa.

This study is based on the following article:

Thyroid function in clinical subtypes of major depression: An exploratory study Konstantinos N Fountoulakis, Apostolos Iacovides, Philippos Grammaticos, George Kaprinis, Per Bech This will appear in BMC Psychiatry 2004, 4 on Monday 15 March.

When published this article will be available free of charge according to BMC Psychiatry's open access policy via: http://www.biomedcentral.com/bmcpsychiatr.

For further information about this research contact the author Dr. Konstantinos N Fountoulakis by phone on 30-310-994-622 or by email at kfount@med.auth.gr.

Alternatively, or for more information about the journal or Open Access, contact Gemma Bradley by phone on 44-0-20-7323-0323 or by email at press@biomedcentral.com.

BMC Psychiatry (http://www.biomedcentral.com/bmcpsychiatr) is published by BioMed Central (http://www.biomedcentral.com), an independent online publishing house committed to providing Open Access to peer-reviewed biological and medical research.

This commitment is based on the view that immediate free access to research and the ability to freely archive and reuse published information is essential to the rapid and efficient communication of science. BioMed Central currently publishes over 100 journals across biology and medicine. In addition to open-access original research, BioMed Central also publishes reviews, commentaries and other non-original-research content. Depending on the policies of the individual journal, this content may be open access or provided only to subscribers.

Contact: Gemma Bradley
press@biomedcentral.com
44-0-20-7323-0323
BioMed Central

• Additional
• References
• Citations